| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Airway Obstruction | D000402 | 13 associated lipids |
| Stomach Ulcer | D013276 | 75 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Hearing Loss, Sensorineural | D006319 | 8 associated lipids |
| Otitis Media | D010033 | 12 associated lipids |
| Carcinoma, Basal Cell | D002280 | 6 associated lipids |
| Bacterial Infections | D001424 | 21 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Stomach Diseases | D013272 | 7 associated lipids |
| Genital Diseases, Female | D005831 | 7 associated lipids |
| Lung Diseases | D008171 | 37 associated lipids |
| Sarcoidosis | D012507 | 13 associated lipids |
| Hyperglycemia | D006943 | 21 associated lipids |
| Carcinoma, Squamous Cell | D002294 | 14 associated lipids |
| Skin Neoplasms | D012878 | 12 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Colitis | D003092 | 69 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Azithromycin treatment failures in syphilis infections--San Francisco, California, 2002-2003. | 2004 | MMWR Morb. Mortal. Wkly. Rep. | pmid:15017376 | |
| Worm HC et al. | High prevalence of Chlamydia pneumoniae infection in cyclosporin A-induced post-transplant gingival overgrowth tissue and evidence for the possibility of persistent infection despite short-term treatment with azithromycin. | 2004 | Nephrol. Dial. Transplant. | pmid:15128877 |
| le Normand Y et al. | [Software modeling for better understanding of pharmacokinetic-pharmacodynamic relationships: application to azithromycin in the treatment of streptococcal tonsillitis and in acute exacerbation fo chronic bronchitis]]. | 2004 Jan-Feb | Therapie | pmid:15199685 |
| Neerja J and Puri SK | Plasmodium yoelii: activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swiss mice. | 2004 Jul-Aug | Exp. Parasitol. | pmid:15363937 |
| Birkenheuer AJ et al. | Efficacy of combined atovaquone and azithromycin for therapy of chronic Babesia gibsoni (Asian genotype) infections in dogs. | 2004 Jul-Aug | J. Vet. Intern. Med. | pmid:15320586 |
| Scheinfeld N | Telithromycin: a brief review of a new ketolide antibiotic. | 2004 Jul-Aug | J Drugs Dermatol | pmid:15303785 |
| Giguère S et al. | Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia. | 2004 Jul-Aug | J. Vet. Intern. Med. | pmid:15320600 |
| Silva-Vergara ML et al. | Azithromycin in the treatment of mucosal leishmaniasis. | 2004 May-Jun | Rev. Inst. Med. Trop. Sao Paulo | pmid:15286825 |
| Hahn DL and Plane MB | Feasibility of a practical clinical trial for asthma conducted in primary care. | 2004 May-Jun | J Am Board Fam Pract | pmid:15226283 |
| Lescano SA et al. | [Evaluation of the efficacy of azithromycin and pyrimethamine, for treatment of experimental infection of mice with Toxoplasma gondii cystogenic strain]. | 2004 Nov-Dec | Rev. Soc. Bras. Med. Trop. | pmid:15765594 |
| Weiss K et al. | Clinical characteristics at initial presentation and impact of dual therapy on the outcome of bacteremic Streptococcus pneumoniae pneumonia in adults. | 2004 Nov-Dec | Can. Respir. J. | pmid:15611810 |
| [The treatment of sexually transmitted diseases in pregnant women with sumamed]. | 2005 | Akush Ginekol (Sofiia) | pmid:16544724 | |
| Beringer P et al. | Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis. | 2005 | Antimicrob. Agents Chemother. | pmid:16304166 |
| Ulrich M et al. | Moxifloxacin and azithromycin but not amoxicillin protect human respiratory epithelial cells against streptococcus pneumoniae in vitro when administered up to 6 hours after challenge. | 2005 | Antimicrob. Agents Chemother. | pmid:16304181 |
| Milbrandt EB and Angus DC | What's in a day? | 2005 | Chest | pmid:16304247 |
| Samsa GP et al. | A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial. | 2005 | Chest | pmid:16304269 |
| Toltzis P | Comparison of amoxicillin with alternative agents for the treatment of acute otitis media in children. | 2005 | Pharmacotherapy | pmid:16305281 |
| Heppner DG et al. | Randomized, controlled, double-blind trial of daily oral azithromycin in adults for the prophylaxis of Plasmodium vivax malaria in Western Thailand. | 2005 | Am. J. Trop. Med. Hyg. | pmid:16282291 |
| Banerjee R et al. | Azithromycin treatment of recurrent respiratory tract infections in children. | 2005 | Pediatr. Infect. Dis. J. | pmid:16282955 |
| Carpenter JW et al. | Pharmacokinetics of azithromycin in the blue and gold macaw (Ara ararauna) after intravenous and oral administration. | 2005 | J. Zoo Wildl. Med. | pmid:17312716 |
| Quach C et al. | Effectiveness of amoxicillin, azithromycin, cefprozil and clarithromycin in the treatment of acute otitis media in children: a population-based study. | 2005 | Pharmacoepidemiol Drug Saf | pmid:15386697 |
| Mitchell WM and Stratton CW | Chlamydia pneumoniae and acute coronary syndrome. | 2005 | N. Engl. J. Med. | pmid:16080250 |
| Baltussen RM et al. | Cost-effectiveness of trachoma control in seven world regions. | 2005 | Ophthalmic Epidemiol | pmid:16019692 |
| Kuper H et al. | Participatory evaluations of trachoma control programmes in eight countries. | 2005 | Trop. Med. Int. Health | pmid:16045463 |
| Matsui H et al. | Azithromycin inhibits the formation of flagellar filaments without suppressing flagellin synthesis in Salmonella enterica serovar typhimurium. | 2005 | Antimicrob. Agents Chemother. | pmid:16048953 |
| Glasheen JJ et al. | The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens. | 2005 | J Gen Intern Med | pmid:16050864 |
| Gaynor BD et al. | Topical ocular antibiotics induce bacterial resistance at extraocular sites. | 2005 | Br J Ophthalmol | pmid:16113356 |
| Block SL et al. | A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study. | 2005 | Clin Ther | pmid:16117986 |
| Milstone A et al. | Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis. | 2005 | Clin Ther | pmid:16117993 |
| Barrett B et al. | Validated HPLC-MS-MS method for determination of azithromycin in human plasma. | 2005 | Anal Bioanal Chem | pmid:16091946 |
| Pieh C et al. | [Cotton wool spots in a 16-year-old girl]. | 2005 | Ophthalmologe | pmid:15095109 |
| Riedner G et al. | Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. | 2005 | N. Engl. J. Med. | pmid:16177249 |
| Holmes KK | Azithromycin versus penicillin G benzathine for early syphilis. | 2005 | N. Engl. J. Med. | pmid:16177256 |
| Tripathi R et al. | Blood schizontocidal activity of azithromycin and its combination with alpha/beta arteether against multi-drug resistant Plasmodium yoelii nigeriensis, a novel MDR parasite model for antimalarial screening. | 2005 | Parasitology | pmid:16178350 |
| Azithromycin extended-release (Zmax) for sinusitis and pneumonia. | 2005 | Med Lett Drugs Ther | pmid:16186790 | |
| Chaudhary C et al. | A pilot study on antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Nepal. | 2005 | Sex Transm Dis | pmid:16205307 |
| West ES et al. | Surgery for Trichiasis, Antibiotics to prevent Recurrence (STAR) Clinical Trial methodology. | 2005 | Ophthalmic Epidemiol | pmid:16033749 |
| Soley CA and Arguedas A | Single-dose azithromycin for the treatment of children with acute otitis media. | 2005 | Expert Rev Anti Infect Ther | pmid:16207162 |
| Alexander ND et al. | An index of community ocular Chlamydia trachomatis load for control of trachoma. | 2005 | Trans. R. Soc. Trop. Med. Hyg. | pmid:15653119 |
| Cárceles CM et al. | Pharmacokinetics of azithromycin after i.v. and i.m. administration to sheep. | 2005 | J. Vet. Pharmacol. Ther. | pmid:16207311 |
| Barker PM et al. | Effect of macrolides on in vivo ion transport across cystic fibrosis nasal epithelium. | 2005 | Am. J. Respir. Crit. Care Med. | pmid:15657462 |
| D'Ignazio J et al. | Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired Pneumonia in adults. | 2005 | Antimicrob. Agents Chemother. | pmid:16189077 |
| Schalock PC and Dinulos JG | Mycoplasma pneumoniae-induced Stevens-Johnson syndrome without skin lesions: fact or fiction? | 2005 | J. Am. Acad. Dermatol. | pmid:15692479 |
| No value in antibiotic therapy for HD. | 2005 | Health News | pmid:16189853 | |
| Preheim LC et al. | Effect of cirrhosis on antibiotic efficacy in a rat model of pneumococcal pneumonia. | 2005 | Diagn. Microbiol. Infect. Dis. | pmid:15698715 |
| Valdes A and Johnson JR | Septic pleuritis and abdominal abscess formation caused by Rhodococcus equi in a foal. | 2005 | J. Am. Vet. Med. Assoc. | pmid:16190597 |
| Arguedas A et al. | A randomized, multicenter, double blind, double dummy trial of single dose azithromycin versus high dose amoxicillin for treatment of uncomplicated acute otitis media. | 2005 | Pediatr. Infect. Dis. J. | pmid:15702045 |
| Biuk D et al. | Serum sickness and uveitis. | 2005 | Coll Antropol | pmid:16193694 |
| Golden MR et al. | Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. | 2005 | N. Engl. J. Med. | pmid:15716561 |
| Ioannidis J and Wilkinson D | HIV: prevention of opportunistic infections. | 2005 | Clin Evid | pmid:16135281 |
| Cárceles CM et al. | Pharmacokinetics of azithromycin after intravenous and intramuscular administration to goats. | 2005 | J. Vet. Pharmacol. Ther. | pmid:15720515 |
| Jacobs RF et al. | Pharmacokinetics of intravenously administered azithromycin in pediatric patients. | 2005 | Pediatr. Infect. Dis. J. | pmid:15665708 |
| Verma A and Dhawan A | Re: Trial of metronidazole vs. azithromycin for treatment of cyclosporine-induced gingival overgrowth. | 2005 | Pediatr Transplant | pmid:15667627 |
| Zar HJ | Neonatal chlamydial infections: prevention and treatment. | 2005 | Paediatr Drugs | pmid:15871630 |
| Bahrami G et al. | High performance liquid chromatographic determination of azithromycin in serum using fluorescence detection and its application in human pharmacokinetic studies. | 2005 | J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. | pmid:15876560 |
| Zou CC and Liang L | Multiple hypoechoic lesions in spleen and Mycoplasma pneumoniae infection. | 2005 | Indian Pediatr | pmid:15876602 |
| Esposito S et al. | Role of atypical bacteria and azithromycin therapy for children with recurrent respiratory tract infections. | 2005 | Pediatr. Infect. Dis. J. | pmid:15876944 |
| Cazzola M et al. | Treatment of acute exacerbation of severe-to-very severe COPD with azithromycin in patients vaccinated against Streptococcus pneumoniae. | 2005 | Respir Med | pmid:15878482 |
| Sommer A | Systemic antibiotics for communitywide trachoma control. | 2005 | Arch. Ophthalmol. | pmid:15883291 |
| Babic Z et al. | Increased activity of Pgp multidrug transporter in patients with Helicobacter pylori infection. | 2005 | World J. Gastroenterol. | pmid:15884110 |
| Grayston JT et al. | Azithromycin for the secondary prevention of coronary events. | 2005 | N. Engl. J. Med. | pmid:15843666 |
| Anderson JL | Infection, antibiotics, and atherothrombosis--end of the road or new beginnings? | 2005 | N. Engl. J. Med. | pmid:15843674 |
| Blessing E et al. | A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with Chlamydia pneumoniae. | 2005 | J. Antimicrob. Chemother. | pmid:15845780 |
| Ritchlin CT | Treatment of reactive arthritis with azithromycin. | 2005 | Curr Rheumatol Rep | pmid:15918991 |
| Máiz Carro L | [Long-term treatment with azithromycin in a patient with idiopathic bronchiectasis]. | 2005 | Arch. Bronconeumol. | pmid:15919012 |
| Sriram S et al. | Pilot study to examine the effect of antibiotic therapy on MRI outcomes in RRMS. | 2005 | J. Neurol. Sci. | pmid:15935383 |
| Palmieri F et al. | Pulmonary cryptosporidiosis in an AIDS patient: successful treatment with paromomycin plus azithromycin. | 2005 | Int J STD AIDS | pmid:16004637 |
| Dinwiddie R | Anti-inflammatory therapy in cystic fibrosis. | 2005 | J. Cyst. Fibros. | pmid:16005266 |
| Spooner K et al. | Azithromcyin might not protect against Treponema pallidum infection or reactivation in HIV type 1-infected patients. | 2005 | Clin. Infect. Dis. | pmid:16007551 |
| Koch DE et al. | Azithromycin extraction from municipal wastewater and quantitation using liquid chromatography/mass spectrometry. | 2005 | J Chromatogr A | pmid:15941034 |
| Patton DL et al. | Significant reduction in inflammatory response in the macaque model of chlamydial pelvic inflammatory disease with azithromycin treatment. | 2005 | J. Infect. Dis. | pmid:15942902 |
| Handrick W et al. | [Pulmonary infection due to Mycobacterium malmoense]. | 2005 | Pneumologie | pmid:15944898 |
| Barlam TF | Expedited treatment for partners of patients with gonorrhea and/or chlamydial infection: impact on rates of persistence or recurrence. | 2005 | Postgrad Med | pmid:15948359 |
| Göbel A et al. | Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. | 2005 | Environ. Sci. Technol. | pmid:15984773 |
| Jover F et al. | Possible azithromycin-associated hiccups. | 2005 | J Clin Pharm Ther | pmid:15985056 |
| Kastelik JA et al. | Azithromycin in cystic fibrosis. | 2005 | Eur. Respir. J. | pmid:15802355 |
| Spiro DM et al. | Antibiotic-induced mesenteric adenopathy in an intussusception mouse model: a randomized, controlled trial. | 2005 | J. Pediatr. Gastroenterol. Nutr. | pmid:15990628 |
| Tabbara KF et al. | Azithromycin prophylaxis and treatment of murine toxoplasmosis. | 2005 | Saudi Med J | pmid:15806206 |
| Kus S et al. | Comparison of efficacy of azithromycin vs. doxycycline in the treatment of acne vulgaris. | 2005 | Clin. Exp. Dermatol. | pmid:15807672 |
| Srinivasan R and Yeo TH | Are newer macrolides effective in eradicating carriage of pertussis? | 2005 | Arch. Dis. Child. | pmid:15723933 |
| Guven MA et al. | The demographic and behavioural profile of women with cervicitis infected with Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum and the comparison of two medical regimens. | 2005 | Arch. Gynecol. Obstet. | pmid:15778862 |
| Kotloff KL et al. | Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine. | 2005 | Infect. Immun. | pmid:15784582 |
| Imamura Y et al. | Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane. | 2005 | Antimicrob. Agents Chemother. | pmid:15793115 |
| Berquand A et al. | Interaction of the macrolide antibiotic azithromycin with lipid bilayers: effect on membrane organization, fluidity, and permeability. | 2005 | Pharm. Res. | pmid:15835753 |
| Dunne MW et al. | A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. | 2005 | J. Infect. Dis. | pmid:15838784 |
| Vainas T et al. | Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease. | 2005 | Eur J Vasc Endovasc Surg | pmid:15749042 |
| Hansen CR et al. | Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study. | 2005 | J. Cyst. Fibros. | pmid:15752679 |
| Janahi IA et al. | Rapidly progressive lung disease in a patient with cystic fibrosis on long-term azithromycin: possible role of mycoplasma infection. | 2005 | J. Cyst. Fibros. | pmid:15752685 |
| GarcÃa Vázquez E et al. | Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone. | 2005 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:15782278 |
| Holas C et al. | A pooled analysis of seven randomized crossover studies of the palatability of cefdinir oral suspension versus amoxicillin/clavulanate potassium, cefprozil, azithromycin, and amoxicillin in children aged 4 to 8 years. | 2005 | Clin Ther | pmid:16507381 |
| Ibarra V et al. | Effect of antibiotic treatment in patients with DEBONEL/TIBOLA. | 2005 | Ann. N. Y. Acad. Sci. | pmid:16481523 |
| Halpern MT et al. | Meta-analysis of bacterial resistance to macrolides. | 2005 | J. Antimicrob. Chemother. | pmid:15772147 |
| Kuzman I et al. | Clinical efficacy and safety of a short regimen of azithromycin sequential therapy vs standard cefuroxime sequential therapy in the treatment of community-acquired pneumonia: an international, randomized, open-label study. | 2005 | J Chemother | pmid:16433194 |
| Altunaiji S et al. | Antibiotics for whooping cough (pertussis). | 2005 | Cochrane Database Syst Rev | pmid:15674946 |
| Drago L et al. | Kinetic bactericidal activity of telithromycin, azithromycin and clarithromycin against respiratory pathogens. | 2005 | APMIS | pmid:16309423 |
| Baciewicz AM et al. | Azithromycin-induced hepatoxicity. | 2005 | Am. J. Med. | pmid:16378809 |
| Piñeyro-López A et al. | Bioavailability of two oral formulations of azithromycin 500 mg: a randomized, open-label, two-period crossover comparison in healthy Mexican adult subjects. | 2005 | Clin Ther | pmid:16330296 |
| Amsden GW | Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? | 2005 | J. Antimicrob. Chemother. | pmid:15590715 |
| Kim MH et al. | Polymorphic ventricular tachycardia with a normal QT interval following azithromycin. | 2005 | Pacing Clin Electrophysiol | pmid:16359290 |
| Dereli T et al. | Azithromycin in the treatment of papulopustular rosacea. | 2005 | J. Dermatol. | pmid:16361757 |